Cardiovascular effects of platelet-activating factor
- 30 April 1991
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 1 (3), 117-121
- https://doi.org/10.1016/1050-1738(91)90005-y
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Rapid neutrophil adhesion to activated endothelium mediated by GMP-140Nature, 1990
- Influence of Thromboxane A2 Receptor Antagonism on Pulmonary Vasoconstrictor ResponsesPediatric Research, 1989
- Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pigProstaglandins, 1987
- PLATELET ACTIVATING FACTOR: A BIOLOGICALLY ACTIVE PHOSPHOGLYCERIDEAnnual Review of Biochemistry, 1986
- Effect of Platelet-Activating Factor (PAF) on Human Cardiac MuscleInternational Archives of Allergy and Immunology, 1986
- Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.JCI Insight, 1984
- Paf‐acether (platelet‐activating factor) increases microvascular permeability and affects endothelium‐granulocyte interaction in microvascular bedsActa Physiologica Scandinavica, 1983
- The actions of Paf‐acether (platelet‐activating factor) on guinea‐pig isolated heart preparationsBritish Journal of Pharmacology, 1983
- Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogsEuropean Journal of Pharmacology, 1983
- In vivo metabolism of a new class of biologically active phospholipids: 1-alkyl-2-acetyl--glycero-3-phosphocholine, a platelet activating-hypotensive phospholipidLife Sciences, 1981